Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

I would also prefer that. And, that is where Brilacidin comes in. That drug will be ready for license negotiations as soon as the Phase 2b is complete, assuming it beats the pants off of Dacto through a greatly shortened course and equivalent outcomes.

Still, do you mean above 200 mg/m2? Then the next cohort will take it there, and there is a chance for another cohort without AEs following that. Yes, I'd like to see MTD >250 mg/m2. But, >200 will also make me happy.

I would like to see mtd well above the therapeutic dose. Even if it takes another year for this glacial trial.